Table 3 Patient characteristics of the validation set for the short-term and long-term predictions
Patient Characteristics | Short-term | Long-term | |||
|---|---|---|---|---|---|
All (n = 1318) | Alpha (n = 6) | Delta (n = 40) | Omicron (n = 35) | (n = 149) | |
Age (median[range]) | 69 [1–104] | 58.5 [50–87] | 60.5 [1–93] | 77 [26–95] | 63 [26–87] |
Age category (n (%)) | |||||
<40 years | 84 (6.37) | 0 (0) | 5 (12.5) | 3 (8.57) | 11 (7.38) |
40–50 years | 107 (8.11) | 0 (0) | 10 (25.0) | 1 (2.86) | 16 (10.7) |
50–60 years | 202 (15.3) | 3 (50.0) | 4 (10.0) | 1 (2.86) | 33 (22.1) |
60–70 years | 298 (22.6) | 1 (16.7) | 5 (12.5) | 5 (14.3) | 46 (30.9) |
70–80 years | 297 (22.5) | 0 (0) | 8 (20.0) | 10 (28.6) | 33 (22.1) |
>80 years | 330 (25.1) | 2 (33.3) | 8 (20.0) | 15 (42.9) | 10 (6.71) |
Sex (n (%)) | |||||
male | 823 (62.4) | 1 (16.7) | 17 (42.5) | 25 (71.4) | 98 (65.8) |
female | 495 (37.6) | 5 (83.3) | 23 (57.5) | 10 (28.6) | 51 (34.2) |
Short-term severity (n (%)) | |||||
severe | 432 (32.8) | 0 (0) | 3 (7.50) | 6 (17.1) | 119 (79.9) |
not severe | 886 (67.2) | 6 (100) | 37 (92.5) | 29 (82.9) | 30 (20.1) |
Long-term symptoms (n (%)) | |||||
yes | – | – | – | – | 102 (31.5) |
no | – | – | – | – | 47 (68.5) |